Verve Therapeutics
VERV
#7327
Rank
NZ$0.59 B
Marketcap
$6.71
Share price
-1.66%
Change (1 day)
-53.67%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$5.20

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.53. In 2022 the company made an earnings per share (EPS) of -$5.10 a decrease over its 2021 EPS that were of -$4.41.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.202.15%
2022-$5.1015.54%
2021-$4.4161.32%
2020-$2.73